Since the interaction of PD-1, expressed on the surface of activated T-cells, and PD-L1, displayed on the surface of tumor cells, results in immunosuppression, the interference mediated by an antibody specific for PD-L1 is a suitable strategy to reduce the suppression of effector T-cells. This evidence concerns the gene CD274 and neoplasm.